HEPATECELLULAR CARCINOMA
Clinical trials for HEPATECELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEPATECELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for HEPATECELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Threat attack on tough liver cancer
Disease control Recruiting nowThis study is testing a new three-part treatment for people with advanced liver cancer that has spread into a major vein in the liver. The treatment combines immunotherapy, a targeted drug, and chemotherapy delivered directly to the liver. The main goal is to see if this combinat…
Matched conditions: HEPATECELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
AI steps in to forecast liver Cancer's return
Knowledge-focused Recruiting nowThis study is testing a new artificial intelligence (AI) tool designed to predict if and how a patient's early-stage liver cancer might return after surgery. Researchers will follow 353 patients for two years after their operation to see if the AI's predictions about high-risk re…
Matched conditions: HEPATECELLULAR CARCINOMA
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC